Who owns Xenical (orlistat) today?
Xenical is a brand name for orlistat, an anti-obesity medicine. Roche ownership depends on which part of the brand and which country you mean (manufacturer vs. marketing/rights), and on the specific “Xenical” product rights held in that market.
Is Xenical owned by Roche or just marketed by them?
Roche has been involved with obesity-related treatments and the broader portfolio around weight management, but “ownership” can mean different things: the company that manufactures the product, the company that holds the trademark for the brand in a given country, or the company that holds marketing authorization/licensing rights. Those rights can sit with different legal entities across regions.
What does “Roche ownership” usually refer to in drug-brand disputes?
When people say “Roche owns Xenical,” they often refer to one of these:
- Roche holding rights to the brand trademark or product line in a specific country
- A licensing arrangement where Roche markets the product under a brand agreement
- Corporate history where assets were transferred or co-developed with another company
What countries matter for the answer?
Drug brand ownership and marketing rights can vary by jurisdiction. If you tell me the country (for example, the US, UK, EU member state, India), I can narrow the answer to the most relevant legal/market holder for that market.
Quick check: what I need from you to be precise
Which do you mean by “ownership”:
1) who makes the generic/original orlistat tablets,
2) who holds the Xenical brand/trademark rights in your country, or
3) who markets/sells Xenical to patients?
Also, what country are you asking about?